[{"address1": "171 Oyster Point Boulevard", "address2": "Suite 400", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 489 9000", "website": "https://www.surrozen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, for treatment of DME/wet AMD/uveitic macular edema; SZN-113 to treat Fuchs' endothelial corneal dystrophy and geographic atrophy; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-\u00df, for the treatment of pulmonary fibrosis. Surrozen, Inc. is headquartered in South San Francisco, California.", "fullTimeEmployees": 40, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig C. Parker M.B.A.", "age": 62, "title": "CEO, President & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 892375, "exercisedValue": 0, "unexercisedValue": 165332}, {"maxAge": 1, "name": "Mr. Charles  Williams", "age": 44, "title": "CFO, COO & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 647639, "exercisedValue": 0, "unexercisedValue": 48919}, {"maxAge": 1, "name": "Dr. Li  Yang Ph.D.", "age": 55, "title": "Executive Vice President of Research", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 579850, "exercisedValue": 0, "unexercisedValue": 35138}, {"maxAge": 1, "name": "Dr. K. Christopher  Garcia Ph.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roeland  Nusse Ph.D.", "age": 74, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1950, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Calvin  Kuo M.D., Ph.D.", "title": "Co-Founder & Member of Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Esther  Jhun", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.26, "open": 10.22, "dayLow": 9.96, "dayHigh": 10.945, "regularMarketPreviousClose": 10.26, "regularMarketOpen": 10.22, "regularMarketDayLow": 9.96, "regularMarketDayHigh": 10.945, "payoutRatio": 0.0, "beta": 0.686, "forwardPE": -2.2382023, "volume": 7831, "regularMarketVolume": 7831, "averageVolume": 14232, "averageVolume10days": 6710, "averageDailyVolume10Day": 6710, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 84606016, "fiftyTwoWeekLow": 6.0, "fiftyTwoWeekHigh": 18.17, "priceToSalesTrailing12Months": 7.940499, "fiftyDayAverage": 10.86628, "twoHundredDayAverage": 10.32662, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6584443, "profitMargins": 0.0, "floatShares": 2189393, "sharesOutstanding": 8494580, "sharesShort": 47857, "sharesShortPriorMonth": 145712, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0056, "heldPercentInsiders": 0.04124, "heldPercentInstitutions": 0.48738998, "shortRatio": 2.92, "shortPercentOfFloat": 0.0064, "impliedSharesOutstanding": 8494580, "bookValue": -6.554, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -63564000, "trailingEps": -21.67, "forwardEps": -4.45, "lastSplitFactor": "1:15", "lastSplitDate": 1702512000, "enterpriseToRevenue": 0.618, "enterpriseToEbitda": -0.273, "52WeekChange": -0.028292656, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 9.96, "targetHighPrice": 42.0, "targetLowPrice": 32.0, "targetMeanPrice": 37.0, "targetMedianPrice": 37.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 34565000, "totalCashPerShare": 10.534, "ebitda": -24097000, "totalDebt": 8469000, "quickRatio": 5.073, "currentRatio": 5.322, "totalRevenue": 10655000, "revenuePerShare": 3.633, "returnOnAssets": -0.33765, "returnOnEquity": -7.67913, "grossProfits": -10477000, "freeCashflow": -8874875, "operatingCashflow": -17628000, "grossMargins": -0.98329, "ebitdaMargins": -2.26157, "operatingMargins": -13.117559, "financialCurrency": "USD", "symbol": "SRZN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Surrozen, Inc.", "marketState": "CLOSED", "longName": "Surrozen, Inc.", "corporateActions": [], "regularMarketTime": 1746216000, "exchange": "NCM", "messageBoardId": "finmb_401948183", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": -0.3000002, "regularMarketDayRange": "9.96 - 10.945", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 14232, "fiftyTwoWeekLowChange": 3.96, "fiftyTwoWeekLowChangePercent": 0.66, "fiftyTwoWeekRange": "6.0 - 18.17", "fiftyTwoWeekHighChange": -8.21, "fiftyTwoWeekHighChangePercent": -0.4518437, "fiftyTwoWeekChangePercent": -2.8292656, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1610375400000, "earningsTimestamp": 1743451516, "earningsTimestampStart": 1743451516, "earningsTimestampEnd": 1743451516, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -21.67, "epsForward": -4.45, "epsCurrentYear": -4.22, "priceEpsCurrentYear": -2.3601897, "fiftyDayAverageChange": -0.90627956, "fiftyDayAverageChangePercent": -0.08340293, "twoHundredDayAverageChange": -0.36662006, "twoHundredDayAverageChangePercent": -0.035502426, "priceToBook": -1.5196826, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-12", "prevName": "Consonance-HFW Acquisition Corp.", "nameChangeDate": "2025-05-02", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -2.9239786, "regularMarketPrice": 9.96, "displayName": "Surrozen", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]